相关临床试验
0
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1950
暂无试验阶段数据
暂无试验数据
暂无试验数据
暂无批准数据
- The Florida Legislature has allocated $2 million to expand FIU's myFORCE program, which personalizes cancer treatment by testing FDA-approved drugs directly against a patient's own tumor cells. - Led by Dr. Diana Azzam, the program previously demonstrated an 83% improvement rate in children with difficult-to-treat cancers in a Nature Medicine-published study conducted with Nicklaus Children's Hospital. - The funding will support core operations, laboratory teams, data analysis, and expansion of the clinical trials network to enable larger multi-institutional studies. - The functional precision medicine approach is particularly valuable for patients with relapsed or treatment-resistant cancers who have exhausted standard therapies.
- Florida becomes the first state to offer comprehensive newborn genetic screening through the Sunshine Genetics Pilot Program, providing free genetic sequencing to identify serious but treatable conditions before symptoms appear. - The initiative receives $7.5 million in state funding plus an additional $2 million from Florida State University, establishing the Institute for Pediatric Rare Diseases as the program's central hub. - The Sunshine Genetics Consortium unites Florida's top universities including FSU, UF, UM, USF, and FIU with hospitals and biotech companies to accelerate research and improve access to treatments for rare childhood diseases. - The program aims to end the "Diagnostic Odyssey" that families endure when seeking answers about rare diseases, with early diagnosis enabling proactive care and better outcomes for affected children.
